EGFR and epithelioid sarcoma: In addition to its antiproliferative and cell death-promoting effect, panobinostat differentially regulated expression of EGFR in epithelioid sarcoma and rhabdoid tumor which, according to our knowledge, has been only described in carcinomas so far.